Dynamic Changes in ST Segment Resolution After Myocardial Infarction and the Association with Microvascular Injury on

James C Weaver1, David D Ramsay, David Rees

  • 1Department of Cardiology, St. George Hospital, Sydney, Australia. james.weaver@sesiahs.health.nsw.gov.au

Heart, Lung & Circulation
|October 15, 2010
PubMed
Abstract

Insights

Persistent ST elevation after myocardial infarction is linked to microvascular injury. Cardiac MRI findings of microvascular obstruction or intramyocardial hemorrhage correlate with ongoing ST elevation, impacting patient prognosis.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Persistent ST elevation post-STEMI suggests poor microvascular perfusion.
  • Cardiac MRI (CMR) assesses microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH), indicators of microvascular damage with prognostic value.
  • MVO and IMH are dynamic in the initial 48 hours post-reperfusion.

Purpose of the Study:

  • To determine if MVO or IMH development impacts ST segment resolution after reperfused STEMI.
  • To investigate the relationship between microvascular injury and ST segment changes.

Main Methods:

  • Serial ECGs were recorded post-PCI in STEMI patients to calculate maximal ST elevation (maxSTE) and deterioration.
  • CMR was used within seven days to assess area at risk (AAR), IMH, infarct size, and MVO.
  • Correlation between ST segment changes and CMR findings was analyzed.

Main Results:

  • 58% of patients had MVO and 41% had IMH.
  • ST segment deterioration was more frequent in patients with MVO or IMH (p=0.03 and p=0.008).
  • MaxSTE was consistently higher in MVO patients after 24 hours; maxSTE at 48-72 hours best correlated with infarct size and microvascular injury.

Conclusions:

  • Microvascular injury, identified by CMR, is associated with persistent ST segment elevation in the first 72 hours post-reperfusion.
  • These findings highlight the prognostic significance of microvascular integrity in STEMI recovery.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...